CD44 and early-onset autosomal dominant Alzheimer disease: Recent evidence suggests that the interaction between APOE and heparan sulfate proteoglycans (HSPGs) may be relevant to the predisposition to, protection from, and potential treatment and prevention of Alzheimer’s disease (AD).